 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval" D: G2 ~3 ?/ G
1 ], ^# ~5 D: _# ^/ K, M' \ h1 M
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
. D3 }( N% p% g. m8 {+ [' y% m/ B0 ^ 3 x) F. h3 ~5 V: N$ k
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007 d3 o, U7 Q0 {) `3 I% z, i1 D
3 w6 N# Z( k. i& w, {4 Y+ k- h% R , v# D& p4 z9 N( v6 c' D" @7 f8 M/ O
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.& l6 W5 R( i" ^# R/ `3 L
- c* r2 X+ p* g v
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."% U, p3 \$ G1 o# ~) K
4 k5 Q7 u' Y" F5 O7 l: R1 s
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
! E Q# V& | P5 `/ [) w) s9 x$ T. d) W6 p8 I
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
) c, U$ G8 V. y' S% {6 V$ r' l) ?" }& n8 g' F
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.3 C! L+ ]* k/ E; |
% @0 w3 x& X9 w"As a scientist, it's one of the highlights of my CAREER," Shan said.
& P7 w9 g1 x2 h; J
) c" x ?; `2 Y F3 b"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."- E- D/ J$ Q g0 m' ^
. [- `9 g& `; r
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.6 {$ C `# F) ?6 n2 [
+ F2 p+ p! L" {0 p8 q) D1 A: LGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
3 r' s" x% f1 K, P; S3 U0 l, D
4 T2 ]" R# q7 S- K% c ?The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman." p' K, U- k! J+ z* b- p
) H7 H8 m+ ?& i$ u8 O; }" g/ \. ^& g- T [# j! @* {$ u
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
发表于 2015-2-28 19:45
